CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...